1. We are a small market in the grand scheme of things. It will come but it's not make or break if approval is delayed.
2. Australian Surgeons can (and do) get access to CardioCel through the Special Access Scheme. So it's not like they can't get a hold of it.
From what I understand, TGA approval is not high on the agenda for Admedus. Quite rightly so they focusing on the US, Europe and Asia where the real gains in growing this company can and will be made. It's not always about the "bloody" Government shafting hardworking Australian technology companies.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus achieves label expansion for CardioCel in Europe
Ann: Admedus achieves label expansion for CardioCel in Europe, page-27
-
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$11.90 |
Change
1.050(9.68%) |
Mkt cap ! $251.5M |
Open | High | Low | Value | Volume |
$11.00 | $11.90 | $10.85 | $504.4K | 45.27K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $11.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.90 | 99 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 500 | 11.050 |
3 | 3407 | 11.000 |
1 | 500 | 10.990 |
1 | 500 | 10.930 |
1 | 915 | 10.900 |
Price($) | Vol. | No. |
---|---|---|
11.900 | 99 | 1 |
11.930 | 80 | 1 |
11.990 | 750 | 1 |
12.000 | 2489 | 1 |
12.050 | 9 | 1 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |